4-Nitropyrocatechol

CAS No. 3316-09-4

4-Nitropyrocatechol( ——— )

Catalog No. M39534 CAS No. 3316-09-4

4-Nitrocatechol is a potent lipoxygenase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Nitropyrocatechol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Nitrocatechol is a potent lipoxygenase inhibitor.
  • Description
    4-Nitrocatechol is a potent lipoxygenase inhibitor.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite, Microbial Metabolite
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    3316-09-4
  • Formula Weight
    155.109
  • Molecular Formula
    C6H5NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL (644.70 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ewa Skrzypczak-Jankun, et al. Soybean lipoxygenase-3 in complex with 4-nitrocatechol. Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):613-5.?
molnova catalog
related products
  • PF-3758309 hydrochlo...

    PF-3758309, also known as PF-03758309, is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity.

  • 4-Hydroxybenzamide

    4-Hydroxybenzamide is a natural product from Berberis pruinosa.

  • Endo-1,4-β-xylanase

    Endo-1,4-β-xylanase (Xylanase), a glycoside hydrolase enzyme that degrades arabinoxylan (AX), is commonly utilized in biochemical research. It specifically hydrolyzes the β-xylosidic bonds linking two d-xylopyranosyl residues in a β-(1,4) configuration .